LHRH-Agonist treatment in clinical and experimental human breast cancer
- 1 November 1985
- journal article
- clinical trial
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 23 (5), 867-873
- https://doi.org/10.1016/s0022-4731(85)80029-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancerBreast Cancer Research and Treatment, 1984
- Therapeutic potential of the lh-rh agonist zoladex (ICI 118630) in the treatment of advanced breast cancer in pre and postmenopausal womenJournal of Steroid Biochemistry, 1984
- LHRH-agonist treatment in metastatic prostate carcinomaEuropean Journal of Cancer and Clinical Oncology, 1984
- Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effectsEuropean Journal of Cancer and Clinical Oncology, 1984
- 286 An analogue of LHRH antagonizes the growth-stimulating effect of oestradiol on human breast cancer cells in culture (MCF-7)Journal of Steroid Biochemistry, 1983
- SUSTAINED GONADAL SUPPRESSION IN FERTILE WOMEN WITH THE LHRH AGONIST BUSERELINClinical Endocrinology, 1983
- The presence of LHRH‐like receptors in Dunning R3327H prostate tumorsFEBS Letters, 1983
- TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCERThe Lancet, 1982
- Reduction of LH-RH pituitary and estradiol uterine binding sites by a superactive analog of luteinizing hormone-releasing hormoneBiochemical and Biophysical Research Communications, 1980
- THE IMPORTANCE OF PITUITARY TUMOUR SIZE IN PATIENTS WITH HYPERPROLACTINAEMIA IN RELATION TO HORMONAL VARIABLES AND EXTRASELLAR EXTENSION OF TUMOURClinical Endocrinology, 1980